Kiniksa Announces Issuance of US Patent for Treatment of Recurrent Pericarditis – BioSpace

10th June 2021

Kiniksa Announces Issuance of US Patent for Treatment of Recurrent Pericarditis BioSpace

OPUS IP on X (formerly Twitter)…

Twitter feed is not available at the moment.

RECENT PATENT NEWS…

Trinity Biotech expands PrePsia patent portfolio to nine patents - Investing.com
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says - Reuters
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says - TradingView
Trinity Biotech Updates on Commercial Progress, Manufacturing Transformation, PrePsia Patent Expansion and Nasdaq Compliance - Quiver Quantitative

UK BUSINESS NEWS…

Gatwick Airport faced water outage after main burst
'A lot of pressure' - SSE Airtricity to increase gas prices by 19%
Fed has 'work to do' if price rises don't ease for Americans, Warsh says
'Cowboy builders' targeted in new government clampdown

Designed by Industrial Action

Copyright © 2026 OPUS IP Limited. All Rights Reserved

OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION